Activation of ET B receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells

British Journal of Pharmacology

Volumn 153, Issue 7, 2008, Pages 1420-1431

  Farhat, N ^a,b   Matouk, C C ^c   Mamarbachi, A M ^b   Marsden, P A ^c   Allen, B G ^a,b   Thorin, E ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Autocrine regulation; Endothelin 1; ET B receptors; mRNA stability; Promoter activity; Vascular endothelial cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DACTINOMYCIN; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RNA POLYMERASE II; ENDOTHELIN B RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CELL VIABILITY; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RNA STABILITY; SIGNAL TRANSDUCTION; ANIMAL; AORTA; ENDOCYTOSIS; METABOLISM; PHYSIOLOGY; SWINE; TIME; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, ENDOTHELIN B; RNA POLYMERASE II; RNA STABILITY; RNA, MESSENGER; SWINE; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 41649092679     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.25     Document Type: Article

References (61)

1. Allen BG, Farhat H, Phuong LL, Chevalier D (2003). Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes. Can J Physiol Pharmacol 81: 95-104.
2. Ambrosino C, Mace G, Galban S, Fritsch C, Vintersten K, Black E et al. (2003). Negative feedback regulation of MKK6 mRNA stability by p38a mitogen-activated protein kinase. Mol Cell Biol 23: 370-381.
3. Blanchard KL, Acquaviva AM, Galson DL, Bunn HF (1992). Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 12: 5373-5385.
4. Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Bremnes T, Paasche JD, Mehlum A, Sandberg C, Bremnes B, Attramadal H (2000). Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 275: 17596-17604.
6. Busse R, Fleming I (2003). Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 241: 24-29.
7. Cheng H-F, Harris RC (2002). Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways. J Biol Chem 277: 45638-45643.
8. Chevalier D, Allen BG (2000a). Purification of myelin basic protein from bovine brain. Prot Exp Purif 18: 229-234.
9. Chevalier D, Allen BG (2000b). Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry 39: 6145-6156.
10. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT et al. (2004). MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279: 10176-10184.
11. Clamp M, Cuff J, Searle SM, Barton GJ (2004). The Jalview Java alignment editor. Bioinformatics 20: 426-427.
12. Douthwaite JA, Lees DM, Corder R (2003). A role for increased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide. Biochem Pharmacol 66: 589-594.
13. Dupuis J (2001). Endothelin-receptor antagonists in pulmonary hypertension. Lancet 358: 1113-1114.
14. Edmunds JW, Mahadevan LC (2004). MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J Cell Sci 117: 3715-3723.
15. Esnault S, Malter JS (2002). Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-α plus fibronectin-activated peripheral blood eosinophils. Blood 99: 4048-4052.
16. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C et al. (2005). The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 280: 24824-24838.
17. Gilsbach R, Kouta M, Bonisch H, Bruss M (2006). Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40: 173-177.
18. Gratton JP, Cournoyer G, Loffler BM, Sirois P, D'Orleans-Juste P (1997). ETB receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension 30: 1204-1209.
19. Gratton JP, Rae GA, Bkaily G, D'Orleans-Juste P (2000). ETB receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit. Hypertension 35: 726-731.
20. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR (1990). Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1: 649-659.
21. Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK et al. (2002). Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J Biol Chem 277: 48379-48385.
22. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002). Multiple control of interleukin-8 gene expression. J Leuk Biol 72: 847-855.
23. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F (1992). Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 19: 753-757.
24. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T (1989). The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 264: 14954-14959.
25. B receptors in vivo. Br J Pharmacol 144: 115-122.
26. Kedzierski RN, Yanagisawa M (2001). Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851-876.
27. Kitazumi K, Tasaka K (1993). The role of c-Jun protein in thrombinstimulated expression of preproendothelin-1 mRNA in porcine aortic endothelial cells. Biochem Pharmacol 46: 455-464.
28. Kotlyarov A, Gaestel M (2002). Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding posttranscriptional regulation of gene expression? Biochem Soc Trans 30 (Part 6): 959-963.
29. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD et al. (1999). MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1: 94-97.
30. Kourembanas S, Marsden PA, McQuillan LP, Faller DV (1991). Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88: 1054-1057.
31. Kurihara H, Yoshima M, Sugiyama M, Takuka F, Yanagisawa M, Masaki T et al. (1989). Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159: 1435-1440.
32. Lafuse WP, Alvarez GR, Zwilling BS (2002). Role of MAP kinase activation in Nranp1 mRNA stability in RAW264.7 macrophages expressing Nramp1Gly169. Cell Immunol 215: 195-206.
33. Larivière R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL (1995). Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J Mol Cell Cardiol 27: 2123-2131.
34. Larsen JK, Gerthoffer WT, Hickey E, Weber LA (1995). Cloning and sequencing of a cDNA encoding the canine HSP27 protein. Gene 161: 305-306.
35. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
36. Malek AM, Greene AL, Izumo S (1993). Regulation of endothelin-1 gene by fluid shear stress is transcriptionally regulated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 90: 5999-6003.
37. Malek AM, Lee IW, Alper SL, Izumo S (1997). Regulation of endothelin-1 gene expression by cell shape and the microfilament network in vascular endothelium. Am J Physiol 273: C1764-C1774.
38. Mawji IA, Marsden PA (2003). Perturbations in paracrine control of the circulation: role of the endothelial-derived vasomediators, endothelin-1 and nitric oxide. Microsc Res Tech 60: 46-58.
39. Mawji IA, Robb GB, Tai SC, Marsden PA (2004a). Role of the 3′-untranslated region of human endothelin-1 in vascular endothelial cells. Contribution to transcript lability and the cellular heat shock response. J Biol Chem 279: 8655-8866.
40. Mawji IA, Robb GB, Tai SC, Marsden PA (2004b). Role of the 3′-untranslated region of human endothelin-1 in vascular endothelial cells. Contribution to transcript lability and the cellular heat shock response. J Biol Chem 279: 8655-8667.
41. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD et al. (2002). MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 277: 3065-3068.
42. Nguyen T-D, Véquaud P, Thorin E (1999). Contribution of endothelin to myogenic tone and α-adrenergic-dependent contraction of rabbit resistance arteries. Cardiovasc Res 43: 755-761.
43. Numahata K, Komagata T, Hirasawa N, Someya K, Xiao YQ, Ohuchi K (2003). Analysis of the mechanism regulating the stability of rat macrophage inflammatory protein-2 mRNA in RBL-2H3 cells. J Cell Biochem 90: 976-986.
44. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y (2002). Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (Lond) 103 (Suppl 48): S68-S71.
45. Okamoto M, Ono M, Uchiumi T, Ueno H, Kohno K, Sugimachi K et al. (2002). Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor β in human cancer cells - transcriptional activation and messenger RNA stability. Biochim Biophys Acta 1574: 24-34.
46. Oksche A, Boese G, Horstmeyer A, Furkert J, Beyermann M, Bienert M et al. (2000). Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol 57: 1104-1113.
47. Øie E, Vigne LE, Tønnessen T, Grøgaard HK, Kjekshus H, Christensen G et al. (1997). Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Physiol 273: H1727-H1736.
48. Peled M, Shaish A, Frishman L, Cohen H, Tal R, Harats D (2006). Endothelin B receptor antagonist increases preproendothelin-1 transcription in bovine aortic endothelial cells and in vivo. J Cardiovasc Pharmacol 47: 668-672.
49. Russell FD, Davenport AP (1999). Secretory pathways in endothelin synthesis. Br J Pharmacol 126: 391-398.
50. Salomonsson L, Pettersson S, Englund MCO, Wiklund O, Ohlsson BG (2002). Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. Eur J Clin Invest 32: 767-774.
51. Sanchez R, MacKenzie A, Farhat N, Nguyen T-D, Stewart DJ, Mercier I et al. (2002). Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell. J Cardiovasc Pharmacol 39: 652-659.
52. Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M (1992). Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313: 307-313.
53. Suck RW, Krupinska K (1996). Repeated probings of western blots obtained from Coomassie brilliant blue-stained or unstained polyacrylamide gels. Biotechniques 21: 418-422.
54. Thorin E (2001). Influence of endothelium-derived NO and ET-1 on ACH-induced coronary contraction in dilated and ischemic CHF. J Cardiovasc Pharmacol 38: 90-98.
55. Thorin E, Hamilton C, Dominiczak AF, Reid JL (1994). Chronic exposure of cultured bovine endothelial cells to oxidized low density lipoprotein abolished prostacyclin release. Arterioscler Thromb 14: 453-459.
56. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ et al. (1992). Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068.
57. Wang X, Barber DA, Lewis DA, McGregor CGA, Sieck GC, Fitzpatrick LA et al. (1997). Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol 273: H1962-H1967.
58. Wang X, Bruderer S, Rafi Z, Xue J, Milburn PJ, Krämer A et al. (1999). Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly. EMBO J 18: 4549-4559.
59. Wang Z, Yue L, White M, Pelletier G, Nattel S (1998). Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98: 2422-2428.
60. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB et al. (1999). The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18: 4969-4980.
61. Yu Y, Zeng H, Lyons S, Carlson A, Merlin D, Neish AS et al. (2003). TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via a posttranscriptional mechanism. Am J Physiol 285: G282-G290.